-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IWGdmW9T+20+h0Mt/Alpez+1UXYx92csvAXA21Lmq6mBnr7DQJJZNjrdHONECG8i iV83l9WmWCrkpptJhvrQlQ== 0000950162-04-001007.txt : 20040907 0000950162-04-001007.hdr.sgml : 20040906 20040907164029 ACCESSION NUMBER: 0000950162-04-001007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040902 FILED AS OF DATE: 20040907 DATE AS OF CHANGE: 20040907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEFIANTE FARMACEUTICA LDA CENTRAL INDEX KEY: 0001168857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15070 FILM NUMBER: 041018957 MAIL ADDRESS: STREET 1: RUA DOS FERREIROS,260 CITY: FUNCHAL MADEIRA STATE: S1 ZIP: 9000-082 FORMER NAME: FORMER CONFORMED NAME: DEFIANTE FARMACEUTICA UNIPESSOAL LDA DATE OF NAME CHANGE: 20020312 FORMER NAME: FORMER CONFORMED NAME: DEFIANTE FARMACEUTICA UNIFESSOAL LDA DATE OF NAME CHANGE: 20020311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA TAU FINANZIARIA SPA CENTRAL INDEX KEY: 0001092601 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15070 FILM NUMBER: 041018958 BUSINESS ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY FORMER NAME: FORMER CONFORMED NAME: SIGMA TAU FINANZIARIA DATE OF NAME CHANGE: 19990805 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019611992 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 regeneform4090704_ex.xml X0202 4 2004-09-02 0 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX.OB 0001092601 SIGMA TAU FINANZIARIA SPA VIA SUDAFRICA 20 00144 ROME ITALY 0 0 1 0 0001168857 DEFIANTE FARMACEUTICA LDA RUA DOS FERREIROS 260 FUNCHAL-MADEIRA S1 9000-082 PORTUGAL 0 0 1 0 Common Stock 2004-09-03 4 X 0 1382488 1.085 A 9875151 I By Defiante Farmaceutica L.d.a. Warrants 1.085 2004-09-02 4 J 0 2 A Common Stock 1382488 2 I By Defiante Farmaceutica L.d.a. Warrants 1.085 2004-09-03 4 X 0 2 D Common Stock 1382488 0 I By Defiante Farmaceutica L.d.a. All shares are owned solely by Defiante Farmaceutica, L.d.a., a wholly-owned subsidiary of Sigma-Tau Finanziaria SpA. Represents warrants that were acquired on June 11, 2003 and initially reported on two Form 4s filed with the Securities and Exchange Commission on June 13, 2003 and January 26, 2004. The Warrants were initially exercisable for a total of 1,350,000 shares of common stock at an average exercise price of $1.111 and had an expiration date of 12/11/04. An amendment to the terms of the warrants dated September 2, 2004 provided that, if the holder exercised the Warrants by not later than September 6, 2004, the Warrants would be exercisable for a total of 1,382,488 shares of common stock at an exercise price of $1.085 per share. Not applicable. Immediately. Exhibit 99 - Joint Filer Information /s/ Antonio Nicolai, Director Sigma-Tau Finanziaria SpA 2004-09-07 EX-99 2 regeneform4090704ex99.txt JOINT FILER INFORMATION Joint Filer Information Name: Defiante Farmaceutica, L.d.a. Address: Rua dos Ferreiros 260 Funchal-Madeira (Portogallo) 9000-082 Designated Filer: Sigma-Tau Finanziaria SpA Issuer & Ticker Symbol: RegeneRx Biopharmaceuticals, Inc. (RGRX.OB) Date of Event Requiring Statement: 9/2/04 Signature: /s/ Carla Arruda Jardim Fernandes Name: Carla Arruda Jardim Fernandes Title: Director -----END PRIVACY-ENHANCED MESSAGE-----